ABSTRACT
The structure and function of small complexes formed between trans-cleaving hammerhead ribozymes and their substrates are being intensely studied in vitro. Conversely, target strands for hammerhead ribozymes in living cells are usually much longer, and cleavage kinetics in vitro of long substrates are usually approximately 100-fold slower. However, on the mechanistic level, not much is known about the influence of substrate length on cleavage kinetics. Here, we describe the influence of the length of the substrate strand on cleavage kinetics in vitro of two trans-cleaving hammerhead ribozymes. Progressive extension of the 3' end of the substrate decreases cleavage kinetics in a length-dependent manner. A six-nucleotide protruding 3' end of helix I is related to a decrease of the cleavage rate by one order of magnitude. Extension of the 5' end of the substrate shows a more complex relationship of the length-related decrease of cleavage activity. Decreased cleavage activity can be compensated by increased magnesium concentrations. An explanation of this finding does not seem to include major influences of the extended substrate on the thermal stability or the global structural arrangement of the three double-strand helices of the hammerhead structure. We hypothesize that long-range influences between the termini of the substrate strand and the catalytic centre could be responsible for decreased cleavage rates.
Subject(s)
RNA, Catalytic/chemistry , RNA, Catalytic/metabolism , Adenosine Triphosphate/metabolism , Autoradiography , Base Sequence , HIV-1/genetics , Humans , Hydrolysis , Kinetics , Magnesium/pharmacology , Molecular Sequence Data , Nucleic Acid Conformation , Oligonucleotides/biosynthesis , Oligonucleotides/chemistry , Phosphorus Isotopes , Proviruses/genetics , RNA, Catalytic/genetics , Structure-Activity Relationship , Substrate SpecificityABSTRACT
Traditional type I glass containers are becoming more unsuitable for packaging modern diagnostics and drugs. When using certain drugs (high-pH formulations, complexing agents, drugs with low dosage, sensitivity to pH-shift or ion release), product degradation can occur, reducing the drug's performance, potency, and shelf-life. To prevent chemical interaction between the container and the content, a coating technology applying a silicon dioxide layer to the internal container surface can bring the solution.
